DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Dol-Gleizes F, Paumelle R, Visentin V. , et al.
Rimonabant, a selective cannabinoid CB1 receptor antagonist, inhibits atherosclerosis in LDL receptor-deficient mice.
Arterioscler Thromb Vasc Biol 2009;
29 (01) 12-18
We do not assume any responsibility for the contents of the web pages of other providers.